![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-7fbea7d8de52f243b1cffa3e6dc1095cf51f43cbe8fc612d201d9cc9b61a7bf0.jpg)
Riluzole for Amyotrophic Lateral Sclerosis Treatment
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.